LSDIF (Lucy Scientific Discovery) Pre-Tax Income : $-9.99 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Lucy Scientific Discovery Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Lucy Scientific Discovery's pretax income for the three months ended in Dec. 2023 was $-1.30 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-9.99 Mil. Lucy Scientific Discovery's pretax margin was -13,040.00%.

Lucy Scientific Discovery Pre-Tax Income Historical Data

The historical data trend for Lucy Scientific Discovery's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lucy Scientific Discovery Pre-Tax Income Chart

Lucy Scientific Discovery Annual Data

Trend

Jun21

Jun22

Jun23

Pre-Tax Income

-4.73

-5.86

-8.99

Lucy Scientific Discovery Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial						-0.67	-4.11	-2.58	-2.00	-1.30

Competitive Comparison of Lucy Scientific Discovery's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Lucy Scientific Discovery's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lucy Scientific Discovery's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lucy Scientific Discovery's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Lucy Scientific Discovery's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

Lucy Scientific Discovery Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Lucy Scientific Discovery's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-5.765	+	-1.257	+	-1.966	+	0	+	0
	=	-8.99

Lucy Scientific Discovery's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.863	+	-0.313	+	-0.128	+	0	+	0
	=	-1.30

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.99 Mil.

Lucy Scientific Discovery (OTCPK:LSDIF) Pre-Tax Income Explanation

Lucy Scientific Discovery's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.304	/	0.01
	=	-13,040.00%

Lucy Scientific Discovery Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Lucy Scientific Discovery's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Lucy Scientific Discovery Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lucy Scientific Discovery Inc (OTCPK:LSDIF) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6

Website

https://www.lucyscientific.com

Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.

Executives

Richard D Nanula	director, officer: Executive Chairman	C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Charles B Nemeroff	director	C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Paul Abramowitz	director	C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Brian Zasitko	officer: Chief Financial Officer	C/O LUCY SCIENTIFIC DISCOVERY, INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Scott M. Reeves	director	C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Christopher Mcelvany	director, officer: President and CEO	C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Livio Susin	director	C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Brittany Kaiser	director	C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Assad J Kazeminy	officer: Chief Scientific Officer	C/O LUCY SCIENTIFIC, INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6